Millipore Sigma Vibrant Logo

538498 RGS4 Inhibitor, CCG- - Calbiochem

RGS4 Inhibitor, CCG- - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: 4-Butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione, CCG203769

Primary Target: RGS4
View This Product on Sigma-Aldrich
538498
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical Formula
C₈H₁₄N₂O₂S

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.38498.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable, thiadiazolidinone based, thiol reactive compound that covalently binds to the regulator of G protein signaling 4 (RGS4) and irreversibly inhibits its activity (IC50 = 17 nM). Exhibits high selectivity over RGS19 and RGS16 (IC50 = 140 nM and 6 µM, respectively) and has negligible effects towards RGS7, RGS8, and papain IC50 = 100, 70, and 100 µM, respectively). Displays ~300-fold greater selectivity over GSK-3beta (IC50 = 5.4 µM). Shown to disrupt RGS4/Gαo interaction and reverse the Gαo-induced membrane translocation of GFP-tagged RGS4 in HEK293 cells (~3 µM). Enhances Gαq-dependent Ca2+ signaling activated by the M3 muscarinic receptor. Potentiates Gαi-dependent muscarinic bradycardia and reverses D2 antagonist raclopride-induced akinesia and bradykinesia in a murine model of the movement disorder in Parkinson's disease.

      Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.
      Catalogue Number538498
      Brand Family Calbiochem®
      Synonyms4-Butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione, CCG203769
      References
      ReferencesBlazer, L.L., et al. 2015. ACS Chem. Neurosci. 6, 311.
      Turner, E., et al. 2012. ACS Med. Chem. Lett.. 3, 146.
      Product Information
      FormColorless oil
      Hill FormulaC₈H₁₄N₂O₂S
      Chemical formulaC₈H₁₄N₂O₂S
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetRGS4
      Primary Target IC<sub>50</sub>17 nM for RGS4 inhibition
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.38498.0001 04054839119484

      Documentation

      RGS4 Inhibitor, CCG- - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      参考資料

      参考資料の概要
      Blazer, L.L., et al. 2015. ACS Chem. Neurosci. 6, 311.
      Turner, E., et al. 2012. ACS Med. Chem. Lett.. 3, 146.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-December-2016 JSW
      Synonyms4-Butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione, CCG203769
      DescriptionA cell-permeable, thiadiazolidinone based, thiol reactive compound that covalently binds to the regulator of G protein signaling 4 (RGS4) and irreversibly inhibits its activity (IC50 = 17 nM). Exhibits high selectivity over RGS19 and RGS16 (IC50 = 140 nM and 6 µM, respectively) and has negligible effects towards RGS7, RGS8, and papain IC50 = 100, 70, and 100 µM, respectively). Displays ~300-fold greater selectivity over GSK-3beta (IC50 = 5.4 µM). Shown to disrupt RGS4/Gαo interaction and reverse the Gαo-induced membrane translocation of GFP-tagged RGS4 in HEK293 cells (~3 µM). Enhances Gαq-dependent Ca2+ signaling activated by the M3 muscarinic receptor. Potentiates Gαi-dependent muscarinic bradycardia and reverses D2 antagonist raclopride-induced akinesia and bradykinesia in a murine model of the movement disorder in Parkinson's disease.
      FormColorless oil
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₈H₁₄N₂O₂S
      Purity≥98% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBlazer, L.L., et al. 2015. ACS Chem. Neurosci. 6, 311.
      Turner, E., et al. 2012. ACS Med. Chem. Lett.. 3, 146.